Muraoka-Cook Rebecca S, Sandahl Melissa, Hunter Debra, Miraglia Leah, Earp H Shelton
University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, 102 Mason Farm Road, Chapel Hill, North Carolina 27599, USA.
Mol Endocrinol. 2008 Oct;22(10):2307-21. doi: 10.1210/me.2008-0055. Epub 2008 Jul 24.
Differentiation of mammary epithelium in vivo requires signaling through prolactin and ErbB4/HER4-dependent mechanisms. Although stimulation of either the prolactin receptor or ErbB4/HER4 results in activation of the transcription factor signal transducer and activator of transcription 5A (STAT5A) and induction of lactogenic differentiation, how these pathways intersect is unknown. We show herein that prolactin signaling in breast cells cooperates with and is substantially enhanced by the receptor tyrosine kinase ErbB4/HER4. Prolactin and the ErbB4/HER4 ligand heparin-binding epidermal growth factor each induced STAT5A tyrosine phosphorylation and nuclear translocation; each pathway required the intracellular tyrosine kinase Janus kinase 2 (JAK2). We found that full prolactin-mediated STAT5A activation and binding to the endogenous beta-casein promoter required ErbB4/HER4 but did not require ErbB1/epidermal growth factor receptor. For example, prolactin-induced STAT5A activity was markedly diminished in cells overexpressing kinase inactive HER4, in cells transfected with small interfering RNAs to specifically knock down endogenous ErbB4/HER4 expression and in cells treated with a small molecule inhibitor that targets ErbB4 kinase. Interestingly, prolactin caused ErbB4/HER4 tyrosine phosphorylation in a JAK2 kinase-dependent manner. Finally, prolactin receptor, ErbB4/HER4, and JAK2 were coimmunoprecipitated from prolactin-treated but not untreated cells. These results suggest that prolactin signaling engages the ErbB4 pathway via JAK2 and that ErbB4 provides an important component of STAT5A-dependent lactogenic differentiation; this pathway integration may help explain the similar deficit in mammary development observed in gene-targeted mice deficient in prolactin receptor, JAK2, ErbB4, or STAT5A.
体内乳腺上皮细胞的分化需要通过催乳素和依赖ErbB4/HER4的机制进行信号传导。尽管催乳素受体或ErbB4/HER4的刺激都会导致转录因子信号转导子和转录激活子5A(STAT5A)的激活以及生乳分化的诱导,但这些途径如何相互作用尚不清楚。我们在此表明,乳腺细胞中的催乳素信号与受体酪氨酸激酶ErbB4/HER4协同作用,并被其显著增强。催乳素和ErbB4/HER4配体肝素结合表皮生长因子均可诱导STAT5A酪氨酸磷酸化和核转位;每条途径都需要细胞内酪氨酸激酶Janus激酶2(JAK2)。我们发现,完全由催乳素介导的STAT5A激活以及与内源性β-酪蛋白启动子的结合需要ErbB4/HER4,但不需要ErbB1/表皮生长因子受体。例如,在过表达激酶失活的HER4的细胞中、在用小干扰RNA转染以特异性敲低内源性ErbB4/HER4表达的细胞中以及在用靶向ErbB4激酶的小分子抑制剂处理的细胞中,催乳素诱导的STAT5A活性显著降低。有趣的是,催乳素以JAK2激酶依赖性方式导致ErbB4/HER4酪氨酸磷酸化。最后,从经催乳素处理而非未处理的细胞中共免疫沉淀出催乳素受体、ErbB4/HER4和JAK2。这些结果表明,催乳素信号通过JAK2参与ErbB4途径,并且ErbB4是STAT5A依赖性生乳分化的重要组成部分;这种途径整合可能有助于解释在催乳素受体、JAK2、ErbB4或STAT5A基因敲除的基因靶向小鼠中观察到的乳腺发育类似缺陷。